200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 630-56-8
630-56-8 | 17-Caproxyprogesterone
CAS No: 630-56-8 Catalog No: AG003DVP MDL No:MFCD00072134
Product Description
Catalog Number:
AG003DVP
Chemical Name:
17-Caproxyprogesterone
CAS Number:
630-56-8
Molecular Formula:
C27H40O4
Molecular Weight:
428.6041
MDL Number:
MFCD00072134
IUPAC Name:
[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate
InChI:
InChI=1S/C27H40O4/c1-5-6-7-8-24(30)31-27(18(2)28)16-13-23-21-10-9-19-17-20(29)11-14-25(19,3)22(21)12-15-26(23,27)4/h17,21-23H,5-16H2,1-4H3/t21-,22+,23+,25+,26+,27+/m1/s1
InChI Key:
DOMWKUIIPQCAJU-LJHIYBGHSA-N
SMILES:
CCCCCC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCC2=CC(=O)CC[C@]12C)C(=O)C
EC Number:
211-138-8
UNII:
276F2O42F5
NSC Number:
17592
Properties
Complexity:
797
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
6
Defined Bond Stereocenter Count:
0
Exact Mass:
428.293g/mol
Formal Charge:
0
Heavy Atom Count:
31
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
428.613g/mol
Monoisotopic Mass:
428.293g/mol
Rotatable Bond Count:
7
Topological Polar Surface Area:
60.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.7
Literature
| Title | Journal |
|---|---|
| An in vitro approach for prioritization and evaluation of chemical effects on glucocorticoid receptor mediated adipogenesis. | Toxicology and applied pharmacology 20180915 |
| Clinical Application of Progesterone for the Prevention of Preterm Birth, 2016. | American journal of perinatology 20160201 |
| Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety. | American journal of obstetrics and gynecology 20160101 |
| Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations. | Seminars in perinatology 20141201 |
| Systemic progesterone therapy--oral, vaginal, injections and even transdermal? | Maturitas 20141101 |
| Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. | American journal of obstetrics and gynecology 20121101 |
| Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation. | American journal of obstetrics and gynecology 20121101 |
| 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. | American journal of obstetrics and gynecology 20121101 |
| The safety of progesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment. | American journal of perinatology 20121001 |
| Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies. | Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 20121001 |
| Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011. | American journal of perinatology 20120901 |
| Technique modifications for reducing the risks from amniocentesis or chorionic villus sampling. | The Cochrane database of systematic reviews 20120815 |
| Pregnancy outcomes of managed Medicaid members prescribed home administration of 17 α-hydroxyprogesterone caproate. | American journal of perinatology 20120801 |
| Source of 17-hydroxyprogesterone caproate in clinical trials. | American journal of obstetrics and gynecology 20120801 |
| Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20120701 |
| The prediction of recurrent preterm birth in patients on 17-alpha-hydroxyprogesterone caproate using serial fetal fibronectin and cervical length. | American journal of obstetrics and gynecology 20120701 |
| Altered arterial stiffness in male-to-female transsexuals undergoing hormonal treatment. | The journal of obstetrics and gynaecology research 20120601 |
| Evidences for antinociceptive effect of 17-α-hydroxyprogesterone caproate in carpal tunnel syndrome. | Journal of molecular neuroscience : MN 20120501 |
| Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection. | Drug development and industrial pharmacy 20120501 |
| Trends in prematurity: what do changes at an urban institution suggest about the public health impact of 17-alpha hydroxyprogesterone caproate? | Maternal and child health journal 20120401 |
| Multigeneration reproductive study of hydroxyprogesterone caproate (HPC) in the rat: laboratory results and clinical significance. | Birth defects research. Part B, Developmental and reproductive toxicology 20120401 |
| Studies examine fetal surgery trade-offs, drug interactions, and uterine rupture. | JAMA 20120328 |
| Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial. | Archives of gynecology and obstetrics 20120301 |
| Metabolism of 17-alpha-hydroxyprogesterone caproate by human placental mitochondria. | Reproductive sciences (Thousand Oaks, Calif.) 20120301 |
| Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. | American journal of obstetrics and gynecology 20120301 |
| 17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. | Reproductive toxicology (Elmsford, N.Y.) 20120101 |
| 17-α hydroxyprogesterone caproate for the prevention of preterm birth. | Women's health (London, England) 20120101 |
| Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials. | BMC pregnancy and childbirth 20120101 |
| Prevention and management of preterm birth. | Journal of pregnancy 20120101 |
| Drugs in traffic: the road to approval. | Nature medicine 20111206 |
| The rates of abnormal glucose challenge tests and gestational diabetes in women receiving 17α-hydroxyprogesterone caproate. | American journal of perinatology 20111201 |
| Iatrogenic autoimmune progesterone dermatitis caused by 17alpha-hydroxyprogesterone caproate for preterm labor prevention. | Cutis 20111101 |
| Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery. | The journal of obstetrics and gynaecology research 20111001 |
| 17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth. | Paediatric drugs 20111001 |
| Medical director to the rescue! | Managed care (Langhorne, Pa.) 20111001 |
| 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial. | Obstetrics and gynecology 20110901 |
| 17-alphahydroxyprogesterone caproate in women with previous spontaneous preterm delivery: does a previous term delivery affect the rate of recurrence? | American journal of obstetrics and gynecology 20110901 |
| Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery. | American journal of obstetrics and gynecology 20110901 |
| Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate. | American journal of obstetrics and gynecology 20110801 |
| Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor. | The journal of obstetrics and gynaecology research 20110701 |
| Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. | American journal of obstetrics and gynecology 20110701 |
| Deus ex Makena? | Obstetrics and gynecology 20110601 |
| Unjustified increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17α-hydroxyprogesterone caproate). | Obstetrics and gynecology 20110601 |
| What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone? | Obstetrics and gynecology clinics of North America 20110601 |
| What is in a name? A higher cost! | South Dakota medicine : the journal of the South Dakota State Medical Association 20110601 |
| 17-hydroxyprogesterone caproate, progesterone, preterm birth prevention, and safety: who decides? Someone should. | American journal of obstetrics and gynecology 20110501 |
| The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage. | American journal of perinatology 20110501 |
| 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial. | American journal of obstetrics and gynecology 20110301 |
| The influence of prior obstetrical history on current 17-hydroxyprogesterone caproate use. | Journal of pregnancy 20110101 |
| Prevention of preterm labour: 2011 update on tocolysis. | Journal of pregnancy 20110101 |
| 17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial. | BMC research notes 20110101 |
| Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20101201 |
| Intramuscular 17α-hydroxyprogesterone caproate administration attenuates immunoresponsiveness of maternal peripheral blood mononuclear cells. | American journal of obstetrics and gynecology 20101201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20101201 |
| Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20101001 |
| Effect of 17-alpha hydroxyprogesterone caproate on the production of tumor necrosis factor-alpha and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants. | Journal of perinatology : official journal of the California Perinatal Association 20100901 |
| 17-alpha-hydroprogesterone caproate and cervical changes. | American journal of obstetrics and gynecology 20100901 |
| Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes. | Drug metabolism and disposition: the biological fate of chemicals 20100501 |
| 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. | American journal of obstetrics and gynecology 20100401 |
| Uterine activity in women receiving 17 alpha-hydroxyprogesterone caproate for the prevention of preterm birth: an observational study. | American journal of perinatology 20100201 |
| Continuous infusion of 17-hydroxyprogesterone caproate into either the fetoplacental or intervillous circulation of a placental cotyledon attenuates vasoconstriction of the fetoplacental arteries by thromboxane mimetic U46619. | American journal of obstetrics and gynecology 20100201 |
| Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. | Obstetrics and gynecology 20100201 |
| Impact of 17P usage on NICU admissions in a managed medicaid population--a five-year review. | Managed care (Langhorne, Pa.) 20100201 |
| Expression of stretch-activated two-pore potassium channels in human myometrium in pregnancy and labor. | PloS one 20100101 |
| Hormonal therapy in advanced or recurrent endometrial cancer. | The Cochrane database of systematic reviews 20100101 |
| Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium. | Fertility and sterility 20091201 |
| The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. | American journal of obstetrics and gynecology 20091001 |
| The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies. | American journal of obstetrics and gynecology 20091001 |
| Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. | American journal of hypertension 20091001 |
| Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery. | Minerva ginecologica 20091001 |
| Progesterone does not prevent preterm births in women with twins. | Southern medical journal 20090901 |
| 17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats. | American journal of obstetrics and gynecology 20090901 |
| Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy. | Obstetrics and gynecology 20090701 |
| Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20090601 |
| Folic acid supplementation and spontaneous preterm birth: adding grist to the mill? | PLoS medicine 20090501 |
| Prematurity in twin pregnancies. | Minerva ginecologica 20090401 |
| Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening. | Proceedings of the National Academy of Sciences of the United States of America 20090324 |
| Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. | Obstetrics and gynecology 20090201 |
| Effect of oral N-acetyl cysteine on recurrent preterm labor following treatment for bacterial vaginosis. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20090101 |
| A randomized trial of cerclage vs. 17 alpha-hydroxyprogesterone caproate for treatment of short cervix. | Journal of perinatal medicine 20090101 |
| The role of progesterone in prevention of preterm birth. | International journal of women's health 20090101 |
| Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS). | Journal of pharmaceutical and biomedical analysis 20081201 |
| Estrus induction and fertility rates in response to exogenous hormonal administration in postpartum anestrous and subestrus bovines and buffaloes. | The Journal of veterinary medical science 20081201 |
| Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. | American journal of obstetrics and gynecology 20081101 |
| ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth. | Obstetrics and gynecology 20081001 |
| Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance. | American journal of obstetrics and gynecology 20081001 |
| 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery. | American journal of perinatology 20080901 |
| The impact of maternal body mass on the effectiveness of 17 alpha-hydroxyprogesterone caproate. | The Journal of reproductive medicine 20080901 |
| Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate. | American journal of obstetrics and gynecology 20080801 |
| Comprehensive screening of acidic and neutral drugs in equine plasma by liquid chromatography-tandem mass spectrometry. | Journal of chromatography. A 20080502 |
| Effect of 17alpha-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer: a randomized trial. | Fertility and sterility 20080501 |
| The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage. | American journal of perinatology 20080501 |
| The effect of esterases on 17alpha-hydroxyprogesterone caproate. | American journal of obstetrics and gynecology 20080201 |
| Progestational agents prevent preterm birth induced by a nitric oxide synthesis inhibitor in the mouse. | In vivo (Athens, Greece) 20080101 |
| Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. | American journal of obstetrics and gynecology 20071201 |
| Progesterone and preterm birth. | The New England journal of medicine 20071129 |
| Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo. | Obstetrics and gynecology 20071001 |
| Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter? | American journal of obstetrics and gynecology 20070901 |
| Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting. | American journal of obstetrics and gynecology 20070901 |
| A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. | The New England journal of medicine 20070802 |
| Progesterone and preterm labor--still no definite answers. | The New England journal of medicine 20070802 |
| Idiopathic vertebral abscess in pregnancy: case report and literature review. | American journal of perinatology 20070601 |
| Gestiva for preventing prematurity: a new view of an old therapy. | Nursing for women's health 20070601 |
| Reducing preterm births. | Reproductive biomedicine online 20070501 |
| 17 Progesterone for preterm birth prevention: a potential 2 billion dollar opportunity. | American journal of obstetrics and gynecology 20070301 |
| Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate. | American journal of obstetrics and gynecology 20070301 |
| Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate. | American journal of obstetrics and gynecology 20070301 |
| Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20070301 |
| Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins. | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 20070201 |
| Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial. | BMC pregnancy and childbirth 20070101 |
| Inhibition of lipid peroxidation induced by hydroxyprogesterone caproate by some conventional antioxidants in goat liver homogenates. | Acta poloniae pharmaceutica 20070101 |
| Population-based case-control teratogenic study of hydroxyprogesterone treatment during pregnancy. | Congenital anomalies 20061201 |
| Massive pre-placental and subchorionic haematoma. | Singapore medical journal 20061201 |
| 17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619. | American journal of obstetrics and gynecology 20061001 |
| The use of progestational agents for preterm birth: lessons from a mouse model. | American journal of obstetrics and gynecology 20061001 |
| Preconception care between pregnancies: the content of internatal care. | Maternal and child health journal 20060901 |
| 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis. | Obstetrics and gynecology 20060901 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Detection of 17alpha-hydroxyprogesterone caproate in equine plasma by gas chromatography/tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20060101 |
| Role of progestogens for the prevention of premature birth. | The Journal of steroid biochemistry and molecular biology 20051201 |
| Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens. | The Journal of steroid biochemistry and molecular biology 20051201 |
| Efficacy and safety of 17alpha-hydroxyprogesterone caproate in hormone replacement therapy. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20051101 |
| 17 alpha-hydroxyprogesterone caproate (17P) usage in a Medicaid managed care plan and reduction in neonatal intensive care unit days. | Managed care (Langhorne, Pa.) 20051001 |
| Does progesterone treatment influence risk factors for recurrent preterm delivery? | Obstetrics and gynecology 20050901 |
| Gestational exposure to hydroxyprogesterone caproate suppresses reproductive potential in male rats. | Die Naturwissenschaften 20050801 |
| Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States. | Obstetrics and gynecology 20050201 |
| Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. | Obstetrics and gynecology 20050201 |
| Hydroxyprogesterone caproate and progesterone increase tumor necrosis factor-alpha production in lipopolysaccharide stimulated whole blood from non-pregnant women. | Journal of perinatal medicine 20050101 |
| Transient parkinsonism: induced by progesterone or pregnancy? | Movement disorders : official journal of the Movement Disorder Society 20041101 |
| [Hormone therapy for uterine corpus cancer--introduction]. | Nihon rinsho. Japanese journal of clinical medicine 20041001 |
| [Conservative hormonal therapy for endometrial cancer]. | Nihon rinsho. Japanese journal of clinical medicine 20041001 |
| 17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study. | Reproductive biomedicine online 20040701 |
| Impairment of male reproduction in adult rats exposed to hydroxyprogesterone caproate in utero. | Die Naturwissenschaften 20040501 |
| [Can progesterone prevent premature birth?]. | Ugeskrift for laeger 20040322 |
| Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro. | Reproductive biology and endocrinology : RB&E 20040101 |
| ACOG Committee Opinion. Use of progesterone to reduce preterm birth. | Obstetrics and gynecology 20031101 |
| Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. | The New England journal of medicine 20030911 |
| Prevention of severe ovarian hyperstimulation syndrome (OHSS) in IVF patients by steroidal ovarian suppression--a prospective randomized study. | Human fertility (Cambridge, England) 20030801 |
| Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. | The New England journal of medicine 20030612 |
| Progesterone and preterm delivery--deja vu all over again. | The New England journal of medicine 20030612 |
| Relative binding activity of new antigestagens with progesterone receptors in human hyperplastic endometrium. | Bulletin of experimental biology and medicine 20021101 |
| [The effect of progestins on endometrial cancer in morphometric evaluation]. | Ginekologia polska 20011201 |
| A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles. | Fertility and sterility 20010801 |
| [Therapy of atypical hyperplasia and adenocarcinoma of the endometrium with the combination of progestins and anticoagulants]. | Voprosy onkologii 20010101 |
| Organ preserving method in the management of atypical endometrial hyperplasia. | European journal of gynaecological oncology 20010101 |
| Preliminary experience with steroidal ovarian suppression for prevention of severe ovarian hyperstimulation syndrome in IVF patients. | Human fertility (Cambridge, England) 20010101 |
| Exploration for drug therapy in endometrial carcinoma. | Chinese medical journal 19960501 |
| [Parameters of estrogen expression in patients with endometrial tumors as prognostic signs of the effectiveness of neoadjuvant antitumor hormone therapy]. | Voprosy onkologii 19960101 |
| [Comparison between the roles of aminoglutethimide and hydroxyprogesterone caproates in the treatment of endometrial cancer]. | Zhonghua fu chan ke za zhi 19950801 |
| Rapid increase in lumbar spine bone density in osteopenic women by high-dose intramuscular estrogen-progestogen injections. A preliminary report. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 19940901 |
| Preferential expression of long form prolactin receptor mRNA in the rat brain during the oestrous cycle, pregnancy and lactation: hormones involved in its gene expression. | The Journal of endocrinology 19940501 |
| Studies on mechanisms and blockade of carcinogenic action of female sex hormones. | Science in China. Series B, Chemistry, life sciences & earth sciences 19940401 |
| [Changes in reproductive hormones levels in the treatment of endometrial precancerous lesion with hydroxyprogesterone caproate]. | Zhonghua fu chan ke za zhi 19940401 |
| Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy. Results of one-institutional prospective clinical trial. | European journal of gynaecological oncology 19930101 |
| Morphological aspects of the hormone-induced pathomorphosis of endometrial carcinoma. | European journal of gynaecological oncology 19930101 |
| Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients. | European journal of gynaecological oncology 19930101 |
| Changes in fibronectin production in rat liver during cirrhotic evolution due to treatment with CCl4 and steroid hormones: correlation with plasmatic fibronectin. | Pathologica 19920101 |
| Progestogen administration in pregnancy may prevent preterm delivery. | British journal of obstetrics and gynaecology 19900201 |
| Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer. | Clinical and experimental obstetrics & gynecology 19900101 |
| [Therapy of mastodynia and simple mastopathy]. | Zentralblatt fur Gynakologie 19900101 |
| Flowers of Hibiscus rosa-sinensis, a potential source of contragestative agent. III: Interceptive effect of benzene extract in mouse. | Contraception 19861101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.